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in order to improve the Treatment Planning Systems (TPS) 
software, so to properly take into account not only the 
normal tissue toxicity in the target region, but also the risk 
of late complications in the whole body [1,2]. All the 
aforementioned issues underline the importance for an 
experimental effort devoted to the precise characterization 
of the neutron production gaining experimental access both 
to the emission point and production energy.  
The technical challenges posed by a neutron detector aiming 
for high detection efficiency and good backtracking precision 
will be addressed within the MONDO (MOnitor for Neutron 
Dose in hadrOntherapy) project. The MONDO main goal is to 
develop a tracking detector targeting fast and ultrafast 
secondary neutrons. 
The main interaction mechanism of fast and ultrafast 
neutrons in plastic scintillators is the elastic scattering with 
hydrogen nuclei. In case of double elastic scattering events, 
if both protons recoil are measured, the neutron energy and 
direction can be reconstructed. The tracking and energy 
resolution achievable on the two recoiling protons drive the 
neutron energy and angular resolutions. The tracker is than 
composed by matrix (10 x 10 x 20 cm3) of squared 
scintillating fiber of 0.250 mm). The fibers are used at the 
same time as target for the elastic n-p scattering of the 
impinging neutrons and as active detector for the recoiling 
protons. The light produced and collected in the fibers will 
be amplified using a triple GEM [3] and acquired using CMOS 
Single Photon Avalanche Diode arrays [4]. 
 
The neutron tracker will measure the neutron production 
yields, as a function of production angle and energy, using 
different therapeutical beams (protons, 12C ions and possibly 
4He and 16O ions).  
The MONDO project and the preliminary test of the different 
components will be presented. 
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Purpose: A growing body of evidence on cancer stem cells 
(CSC) relates their presence in tumours to poor treatment 
outcome. Symmetrical division of CSC during therapy is a key 
factor that contributes to repopulation and treatment 
failure. However, the literature lacks quantification of the 
CSC fraction and their division pattern. Head and neck 
cancers (HNC) are challenging due to high hypoxic content 
and repopulation ability by CSCs. The aim of this work was to 
quantify the symmetrical division of CSC in a hypoxic HNC 
model treated with hyperfractionated radiotherapy and 
assess tumour response as a function of the interplay 
between CSC and the hypoxic fraction.  
Methods: A Monte Carlo technique was employed to grow a 
HNC consisting of CSC, differentiated and quiescent cells. For 
a biologically realistic growth, the initial symmetrical division 
probability of CSC was 1.9%, leading to a pre-treatment CSC 
population of 5.9%. The model considers various hypoxia 
levels as a function of the mean partial oxygen tension, from 
3mmHg to 10mmHg. CSC radioresistance was established 
according to literature [1] and adapted for HNC. 
Results: Initial CSC fraction changes during treatment due to 
repopulation, radioresistance and hypoxia. Figure 1 shows 
the variation of CSC fraction during therapy for three hypoxic 
scenarios. The figure shows that in mildly hypoxic tumours (9 
mmHg) the fraction of CSCs during treatment overtakes the 
fraction of CSC in severely hypoxic ones (3 mmHg). It nearly 
appears that hypoxia keeps the CSC subpopulation under 
control. This behaviour is due to the fact that in well-
oxygenated tumors CSCs are the most resistant subpopulation 
and they outlive non-stem cells, while in hypoxic tumors 
there are hypoxic resistant subpopulations as well as CSCs, 
thus the hypoxic content and CSC fraction are intertwined. 
 
 
While hyperfractionation (1.2Gy in 70 fractions) is likely to 
be the most optimal radiotherapy schedule for advanced HNC 
[2] the model shows that if repopulation occurs via 
symmetrical division of CSCs with a probability greater than 
5%, radiotherapy as a sole agent is not efficient for hypoxic 
HNC (table 1). However, oxic HNC benefit from 
hyperfractionation even for larger probabilities of 
symmetrical division, thus an overall dose of 84Gy in two 
1.2Gy daily fractions is effective to overcome repopulation. 
Conclusions: Quantitative evaluation of CSCs and hypoxia are 
crucial for designing successful treatment regimens for 
resistant subpopulations. 
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Purpose: Despite recent advancements in radiotherapy and 
radiosurgery, significant limitations remain. Hadrontherapy, 
which has been in clinical use for more than 15 years, has 
shown remarkable effectiveness. However, it still could 
benefit from a lower impact on non-targeted tissues to allow 
its administration at higher doses. This is the reason why we 
propose a new approached called hadron minibeam radiation 
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therapy (hadron MBRT). The technique is based on the well 
established tissue-sparing effect of arrays of parallel, thin or 
small beams, observed in studies performed with synchrotron 
radiation [1-2]. In parallel, significant tumor growth delay 
was observed in highly aggressive tumors by using interlaced 
irradiations [1-3]. Hadron MBRT combines the advantages of 
MBRT with the high dose conformability and the remarkable 
biological effectiveness of hadrontherapy. This novel strategy 
might guarantee tissue recovery and reduce the side effects 
of radiation in healthy tissues. The main goal of this study 
was to explore this new approach from a dosimetric point of 
view and to verify its technical feasibility at a clinical center 
(HIT, Germany). In particular, carbon and oxygen minibeams 
were studied. 
Materials/methods: Carbon and oxygen minibeams were 
generated through a tungsten multislit collimator with line 
apertures of 700 μm separated by 3500 μm. Scanned 12C and 
16O pencil beams were used to cover a given irradiation field 
size (1x1 cm2) and a spread out Bragg peak (SOBP) region of 
5 cm at 8 cm-depth in water. Radiochromic films (EBT3) were 
placed at several depths in a solid-water slab phantom to 
evaluate dose distributions. Quenching effects of these films 
were also assessed and results were accordingly corrected.  
As a figure of merit, the ratio between the central dose of 
one minibeam (peak dose) and the dose in the middle of two 
consecutive beams (valley dose) was evaluated. This 
magnitude, named peak-to-valley dose ratio (PVDR), is a very 
relevant magnitude in such spatially fractionated techniques 
[4]. 
Results: The measured lateral dose profiles in carbon and 
oxygen MBRT consisted in a pattern of peaks and valleys, 
which prove the technical feasibility of this approach. This 
first dosimetric study showed PVDR values around 10-20 in 
the first centimeters of the phantom. PVDR values 
progressively decrease up to around 5 at 8-cm-depth. These 
PVDR values are in the order of the ones obtained in x-rays 
MBRT, for which biological effectiveness has already been 
proven.  
Conclusions: This is the first exploratory study that 
experimentally proves the technical feasibility of hadron 
MBRT at a clinical center. The PVDR values obtained showed 
the potential of this radiotherapy approach, which might 
allow reducing side effects in the healthy tissues. Animal 
experiments are warranted. 
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Purpose: One strategy to improve the clinical outcome in 
radiotherapy (RT) is to increase the dose effects in the 
tumor. This can be achieved by using specific nanoparticles 
(NP). Numerous studies have shown an enhanced 
effectiveness of tumor cell killing when NP were associated 
to irradiation [1-3]. However, the mechanisms of action are 
not yet clear. In addition to the damage due to a possible 
local dose enhancement, the interaction of NP with essential 
biological macromolecules could lead to changes in the 
cellular function, such as cell arrest at radiosensitive phases 
[4]. These effects, which could be amplified with a 
subsequent irradiation, might increase their anticancer 
effectiveness. Along this line, in this study we used F98 
glioma rat cells as an in vitro model to evaluate the 
intracellular biochemical changes induced by x-ray 
irradiations in combination with Gadolinium NP by using 
Fourier transform infrared microspectroscopy (FTIR). FTIR 
allows in situ chemical structure determination of 
intracellular biomolecules. In addition, this technique has 
significantly contributed to study apoptosis, as well as cell 
cycle and cell death modes.  
Materials/methods: FTIR measurements were performed 
using the internal source of infrared radiation at SESAME 
synchrotron (Jordan). Principal Component Analysis (PCA) 
was performed to show the variances between the different 
sets of spectra.  
Results: Noticeable spectra alterations in the presence or 
absence of NP were detected in the proteins, DNA and lipids 
regions, indicating changes in the cellular function (even in 
the absence of radiation). In particular, biochemical changes 
related to apoptosis were detected. These include a shift 
toward the low wavenumbers in the amide I and II bands, 
relative amplitude changes in the CH2 and CH3 stretching 
modes, along with DNA chromatin condensation indications 
[5]. The figure below shows an example of PCA analysis in 
the DNA region of the infrared spectral range in the presence 
and absence of NP for a dose deposition of 10 Gy.  
 
 
 
Conclusion: This is one of the first research studies 
performed at the Emira laboratory of the SESAME Synchrotron 
(Jordan). This infared work provides new insights on the 
biochemical effects induced by the combination of 
radiotherapy and nanoparticles, for which the full 
mechanisms of interaction are not well known up to now. 
Results will be discussed in relation to cell viability studies. 
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We present the first results obtained with a detector, called 
Large Area Pixelized Detector (LAPD), dedicated to the beam 
ballistic control in the context of hadrontherapy.  
The purpose is to control the ballistics of the beam delivered 
to the patient by in-beam and real time detection of 
secondary particles, emitted during its irradiation. These 
particles could be high energy photons (γ prompt), or charged 
particles like protons, or 511 keV γ from the annihilation of a 
